Results summary | View all lists in L2L MDB | View all genes in S01B.profile.u50 |
Down-regulated at 6hr following treatment of peripheral blood mononuclear cells (PBMC) with recombinant IL-2. enrichment: 4.58-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
212974_AT | DENND3 | ![]() |
![]() |
DENN/MADD domain containing 3 | |||||||||
210785_S_AT | C1ORF38 | ![]() |
![]() |
||||||||||
204526_S_AT | TBC1D8 | G | S | ![]() |
![]() |
TBC1 domain family, member 8 (with GRAM domain) | |||||||
209185_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 | |||||
221592_AT | TBC1D8 | G | S | ![]() |
![]() |
TBC1 domain family, member 8 (with GRAM domain) | |||||||
209184_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 |